Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
BACKGROUND: A comprehensive overview of neurologic complications among survivors of central nervous system (CNS) tumors in childhood is lacking. We aimed to investigate the risk for these disorders in a large, population-based study with outcome measures from nationwide hospital registries. METHODS:...
Published in: | Neuro-Oncology |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Text |
Language: | English |
Published: |
Oxford University Press
2019
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303468/ http://www.ncbi.nlm.nih.gov/pubmed/29850875 https://doi.org/10.1093/neuonc/noy094 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:6303468 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:6303468 2023-05-15T16:51:45+02:00 Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study Kenborg, Line Winther, Jeanette Falck Linnet, Karen Markussen Krøyer, Anja Albieri, Vanna Holmqvist, Anna Sällfors Tryggvadottir, Laufey Madanat-Harjuoja, Laura Maria Stovall, Marilyn Hasle, Henrik Olsen, Jørgen H 2019-01 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303468/ http://www.ncbi.nlm.nih.gov/pubmed/29850875 https://doi.org/10.1093/neuonc/noy094 en eng Oxford University Press http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303468/ http://www.ncbi.nlm.nih.gov/pubmed/29850875 http://dx.doi.org/10.1093/neuonc/noy094 © The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Pediatric Neuro-Oncology Text 2019 ftpubmed https://doi.org/10.1093/neuonc/noy094 2020-01-05T01:16:04Z BACKGROUND: A comprehensive overview of neurologic complications among survivors of central nervous system (CNS) tumors in childhood is lacking. We aimed to investigate the risk for these disorders in a large, population-based study with outcome measures from nationwide hospital registries. METHODS: We identified 4858 five-year survivors with diagnoses of CNS tumor in childhood in Denmark, Iceland, Finland, and Sweden in 1943–2007, and 166658 matched population comparison subjects. Inpatient discharge diagnoses of neurologic disorders were used to calculate relative risks (RRs) and absolute excess risks (AERs). RESULTS: A neurologic disorder was verified in 1309 survivors, while 92.4 were expected, yielding an overall RR of 14.2 (95% confidence interval [CI]: 13.3–15.1) and an AER of 20 hospitalizations per 1000 persons per year. The risks remained increased more than 20 years after diagnosis (RR: 6.3, 95% CI: 5.6–7.2; AER: 11, 9–12). The most frequent diagnoses were epilepsy (affecting 14.1% of all survivors) followed by hydrocephalus (9.5%) and paralytic syndromes (4.2%), with RRs of 28.7 (95% CI: 26.0–31.6), 243 (95% CI: 190–311), and 40.3 (95% CI: 33.1–49.2), respectively. Of these outcomes, 30%–40% were diagnosed prior to or synchronously with the CNS tumor. The survivors had highly increased RRs for infectious diseases of the CNS, disorders of cranial nerves, and degenerative diseases of the nervous system. CONCLUSIONS: Survivors of childhood CNS tumors are at markedly increased risk for neurologic disorders throughout their lives. Health care professionals must be aware of survivors who might benefit from preventive interventions and intensive follow-up. Text Iceland PubMed Central (PMC) Neuro-Oncology 21 1 125 136 |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
Pediatric Neuro-Oncology |
spellingShingle |
Pediatric Neuro-Oncology Kenborg, Line Winther, Jeanette Falck Linnet, Karen Markussen Krøyer, Anja Albieri, Vanna Holmqvist, Anna Sällfors Tryggvadottir, Laufey Madanat-Harjuoja, Laura Maria Stovall, Marilyn Hasle, Henrik Olsen, Jørgen H Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study |
topic_facet |
Pediatric Neuro-Oncology |
description |
BACKGROUND: A comprehensive overview of neurologic complications among survivors of central nervous system (CNS) tumors in childhood is lacking. We aimed to investigate the risk for these disorders in a large, population-based study with outcome measures from nationwide hospital registries. METHODS: We identified 4858 five-year survivors with diagnoses of CNS tumor in childhood in Denmark, Iceland, Finland, and Sweden in 1943–2007, and 166658 matched population comparison subjects. Inpatient discharge diagnoses of neurologic disorders were used to calculate relative risks (RRs) and absolute excess risks (AERs). RESULTS: A neurologic disorder was verified in 1309 survivors, while 92.4 were expected, yielding an overall RR of 14.2 (95% confidence interval [CI]: 13.3–15.1) and an AER of 20 hospitalizations per 1000 persons per year. The risks remained increased more than 20 years after diagnosis (RR: 6.3, 95% CI: 5.6–7.2; AER: 11, 9–12). The most frequent diagnoses were epilepsy (affecting 14.1% of all survivors) followed by hydrocephalus (9.5%) and paralytic syndromes (4.2%), with RRs of 28.7 (95% CI: 26.0–31.6), 243 (95% CI: 190–311), and 40.3 (95% CI: 33.1–49.2), respectively. Of these outcomes, 30%–40% were diagnosed prior to or synchronously with the CNS tumor. The survivors had highly increased RRs for infectious diseases of the CNS, disorders of cranial nerves, and degenerative diseases of the nervous system. CONCLUSIONS: Survivors of childhood CNS tumors are at markedly increased risk for neurologic disorders throughout their lives. Health care professionals must be aware of survivors who might benefit from preventive interventions and intensive follow-up. |
format |
Text |
author |
Kenborg, Line Winther, Jeanette Falck Linnet, Karen Markussen Krøyer, Anja Albieri, Vanna Holmqvist, Anna Sällfors Tryggvadottir, Laufey Madanat-Harjuoja, Laura Maria Stovall, Marilyn Hasle, Henrik Olsen, Jørgen H |
author_facet |
Kenborg, Line Winther, Jeanette Falck Linnet, Karen Markussen Krøyer, Anja Albieri, Vanna Holmqvist, Anna Sällfors Tryggvadottir, Laufey Madanat-Harjuoja, Laura Maria Stovall, Marilyn Hasle, Henrik Olsen, Jørgen H |
author_sort |
Kenborg, Line |
title |
Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study |
title_short |
Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study |
title_full |
Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study |
title_fullStr |
Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study |
title_full_unstemmed |
Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study |
title_sort |
neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an adult life after childhood cancer in scandinavia (aliccs) study |
publisher |
Oxford University Press |
publishDate |
2019 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303468/ http://www.ncbi.nlm.nih.gov/pubmed/29850875 https://doi.org/10.1093/neuonc/noy094 |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303468/ http://www.ncbi.nlm.nih.gov/pubmed/29850875 http://dx.doi.org/10.1093/neuonc/noy094 |
op_rights |
© The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) |
op_doi |
https://doi.org/10.1093/neuonc/noy094 |
container_title |
Neuro-Oncology |
container_volume |
21 |
container_issue |
1 |
container_start_page |
125 |
op_container_end_page |
136 |
_version_ |
1766041849123831808 |